1:"$Sreact.fragment"
c:I[5014,["/_next/static/chunks/236aw131lsvrc.js","/_next/static/chunks/1-8s9_t85wwr4.js","/_next/static/chunks/3p66hazs5-2j3.js","/_next/static/chunks/3fd54t--kwrrb.js","/_next/static/chunks/2-pirf99i-4ly.js"],"default"]
d:I[39273,["/_next/static/chunks/236aw131lsvrc.js","/_next/static/chunks/1-8s9_t85wwr4.js","/_next/static/chunks/3p66hazs5-2j3.js","/_next/static/chunks/3fd54t--kwrrb.js","/_next/static/chunks/2-pirf99i-4ly.js"],"ConcentrationTables"]
e:I[28550,["/_next/static/chunks/236aw131lsvrc.js","/_next/static/chunks/1-8s9_t85wwr4.js","/_next/static/chunks/3p66hazs5-2j3.js","/_next/static/chunks/3fd54t--kwrrb.js","/_next/static/chunks/2-pirf99i-4ly.js"],"ConcentrationChart"]
f:I[90981,["/_next/static/chunks/236aw131lsvrc.js","/_next/static/chunks/1-8s9_t85wwr4.js","/_next/static/chunks/3p66hazs5-2j3.js","/_next/static/chunks/3fd54t--kwrrb.js","/_next/static/chunks/2-pirf99i-4ly.js"],"DetectionTimeline"]
10:I[85513,["/_next/static/chunks/236aw131lsvrc.js","/_next/static/chunks/1-8s9_t85wwr4.js","/_next/static/chunks/3p66hazs5-2j3.js","/_next/static/chunks/3fd54t--kwrrb.js","/_next/static/chunks/2-pirf99i-4ly.js"],"FluidPersistenceTable"]
11:I[85513,["/_next/static/chunks/236aw131lsvrc.js","/_next/static/chunks/1-8s9_t85wwr4.js","/_next/static/chunks/3p66hazs5-2j3.js","/_next/static/chunks/3fd54t--kwrrb.js","/_next/static/chunks/2-pirf99i-4ly.js"],"TissuePersistenceTable"]
12:I[97367,["/_next/static/chunks/236aw131lsvrc.js","/_next/static/chunks/1-8s9_t85wwr4.js","/_next/static/chunks/3p66hazs5-2j3.js"],"OutletBoundary"]
13:"$Sreact.suspense"
2:T3bb7,{"@context":"https://schema.org","@type":["MedicalWebPage","Dataset"],"name":"Spike Protein Measured Levels & Durations","description":"Human pg/mL circulating levels vs. in vitro µg/mL experimental concentrations. Persistence in blood up to ~709 days and tissues. Dose-translation from Spike Protein Dose review.","dateModified":"2026-07-06","keywords":["spike protein concentration","pg/mL","µg/mL","SARS-CoV-2 spike protein"],"about":{"@type":"MedicalCondition","name":"SARS-CoV-2 Spike Protein Persistence"},"variableMeasured":[{"@type":"PropertyValue","name":"Human — circulating — Plasma (adolescents, mRNA myocarditis) (Free spike protein)","value":"~34","unitText":"pg/mL","description":"Detected in myocarditis cases; not in asymptomatic controls"},{"@type":"PropertyValue","name":"Human — circulating — Plasma (post-vaccine sequelae cohort) (Circulating spike)","value":"Low pg/mL (subset positive)","unitText":"pg/mL","description":"Persistent detection months post-vaccination in symptomatic subset"},{"@type":"PropertyValue","name":"Human — circulating — Plasma (research assays) (Spike protein)","value":"Sub-pg/mL to low pg/mL","unitText":"pg/mL","description":"Assay limit of detection"},{"@type":"PropertyValue","name":"Human — circulating — Blood/plasma (Spike protein)","value":"Trace–low pg/mL","unitText":"pg/mL","description":"Persistence up to ~709 days in outlier cohorts"},{"@type":"PropertyValue","name":"Human — circulating — Plasma (long COVID cohorts) (Spike protein)","value":"Variable; often below assay LOD","unitText":"pg/mL","description":"No consistent plasma spike–symptom correlation in some studies"},{"@type":"PropertyValue","name":"Human — tissue — Blood, heart, liver, spleen, brain-meninges (autopsy/biopsy) (Vaccine-derived spike + mRNA)","value":"Qualitative IHC/PCR positive","unitText":"qualitative","description":"Up to ~6 months; brain borders up to ~4 years (limited N)"},{"@type":"PropertyValue","name":"Human — tissue — Lymph node germinal centers (Vaccine antigen)","value":"Localized antigen (not circulating)","unitText":"qualitative","description":"Persistence 8+ months"},{"@type":"PropertyValue","name":"In vitro (experimental) — hiPSC-derived neural stem cells (Spike protein / toxin-like peptides)","value":"Up to 20","unitText":"µg/mL","description":"No impact on cell viability at ≤20 µg/mL"},{"@type":"PropertyValue","name":"In vitro (experimental) — Microvascular endothelial cells (S1 subunit)","value":"~10 (~50 nM S1)","unitText":"µg/mL","description":"~50% reduction in cell viability (approximate LD50)"},{"@type":"PropertyValue","name":"In vitro (experimental) — Endothelial cells + complement (S1 subunit)","value":"µg/mL range (S1)","unitText":"µg/mL","description":"Complement activation, platelet aggregation"},{"@type":"PropertyValue","name":"In vitro (experimental) — Cell-free recombinant spike (Recombinant spike (degradation by nattokinase))","value":"2.5–25","unitText":"µg/mL","description":"Spike degradation demonstrated"},{"@type":"PropertyValue","name":"In vitro (experimental) — Cell-free fibrinogen (S1 subunit)","value":"Low µg/mL range (S1)","unitText":"µg/mL","description":"Amyloidogenic fibrin resistant to fibrinolysis"},{"@type":"PropertyValue","name":"In vitro (experimental) — Human cardiac pericytes (Full spike)","value":"Low ng–µg/mL range","unitText":"ng/mL","description":"Pericyte dysfunction via CD147 (non-infective)"},{"@type":"PropertyValue","name":"In vitro (experimental) — Primary human trophoblasts + BeWo cell line (S1 subunit)","value":"100","unitText":"ng/mL","description":"Inflammatory response, cytotoxic/antiproliferative effect, G2-M arrest, disrupted glucose/folate/amino-acid transporters"},{"@type":"PropertyValue","name":"In vitro (experimental) — Co-cultured human alveolar epithelial cells + macrophages (Recombinant S1 protein)","value":"0.1–10","unitText":"µg/mL","description":"Dose-dependent LDH release, IL-6 and TNF-α production; 10 µg/mL matched LPS-induced injury by day 3"},{"@type":"PropertyValue","name":"In vitro (experimental) — BEAS-2B lung epithelial cells + MRC-5 fibroblasts (Spike protein)","value":"1,000","unitText":"ng/mL","description":"Increased IL-6, TNF-α, CXCL1, CXCL3; epithelial-mesenchymal transition via GADD45A upregulation"},{"@type":"PropertyValue","name":"In vitro (experimental) — Citrated whole blood (platelets) (Recombinant spike (Ancestral, Alpha, Delta, Omicron variants))","value":"2–20","unitText":"ng/mL","description":"Decreased platelet count, increased mean platelet volume, platelet clumping/activation — most pronounced with Delta/Alpha at 20 ng/mL"},{"@type":"PropertyValue","name":"In vitro (experimental) — Ex vivo whole blood (platelets) (Recombinant spike (Alpha, Beta, Gamma, Delta variants))","value":"5","unitText":"µg/mL","description":"No significant change in platelet aggregability, P-selectin, PAC-1 binding, or thromboelastography parameters"},{"@type":"PropertyValue","name":"In vitro (experimental) — A549 lung epithelial cells (S1 subunit)","value":"100","unitText":"ng/mL","description":"NLRP3 inflammasome activation, IL-6/IL-1β/IL-18 release"},{"@type":"PropertyValue","name":"In vitro (experimental) — BEAS-2B and A549 epithelial cells (S1 or S2 subunit)","value":"1","unitText":"µg/mL","description":"S1 increased IL-6 in BEAS-2B; miR-149-5p largely unaffected (contrasts with poly(I:C) response)"},{"@type":"PropertyValue","name":"In vitro (experimental) — Mouse lung epithelial cells (S2 subunit)","value":"500","unitText":"ng/mL","description":"Proinflammatory cytokine/chemokine induction (Tnf-α, Il1β, Il6, Ccr2, Ccr5), attenuated by IGFBP2 overexpression"},{"@type":"PropertyValue","name":"In vitro (experimental) — A549 lung epithelial cells (S1 subunit (Wuhan and Omicron variants))","value":"100","unitText":"ng/mL","description":"NLRP3/MAPK-mediated IL-6, IL-1β, IL-18 secretion, dose-dependently reduced by luteolin/H. perforata extract"},{"@type":"PropertyValue","name":"In vitro (experimental) — A549 lung epithelial cells (S1 subunit)","value":"100","unitText":"ng/mL","description":"NLRP3 inflammasome activation via JAK1/STAT3, reduced by Perilla frutescens luteolin fraction"},{"@type":"PropertyValue","name":"In vitro (experimental) — A549 lung epithelial cells (S1 subunit)","value":"100","unitText":"ng/mL","description":"NLRP3 inflammasome activation via Akt/MAPK/AP-1, reduced by hesperetin"},{"@type":"PropertyValue","name":"In vitro (experimental) — Xenopus oocytes expressing human nAChR subunits (Spike receptor-binding domain (RBD))","value":"1","unitText":"µg/mL","description":"Marked reduction in current amplitude at α4β2 and α4α6β2 nAChR subtypes; equivocal at α3α5β4; absent at α3β4/α7"},{"@type":"PropertyValue","name":"In vivo — animal models — Mouse (spike administration or mRNA) (Spike protein or encoding mRNA)","value":"Systemic exposure (dose per kg)","unitText":"varies","description":"Myocarditis recapitulated"},{"@type":"PropertyValue","name":"In vivo — animal models — hACE2 mice (spike-induced PASC model) (Spike protein)","value":"Systemic spike exposure","unitText":"varies","description":"Brain fog–like cognitive phenotype"}],"citation":[{"@type":"ScholarlyArticle","name":"Circulating spike protein detected in post–COVID-19 mRNA vaccine myocarditis","author":"Yonker LM, et al.","isPartOf":{"@type":"Periodical","name":"Circulation"},"datePublished":"2023","sameAs":"https://doi.org/10.1161/CIRCULATIONAHA.122.061730","url":"https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.061730"},{"@type":"ScholarlyArticle","name":"Persistent circulating SARS-CoV-2 spike protein in individuals post-COVID-19 vaccination","author":"Swank DL, et al.","isPartOf":{"@type":"Periodical","name":"Circulation"},"datePublished":"2023","sameAs":"https://doi.org/10.1161/CIRCULATIONAHA.122.061025","url":"https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.061025"},{"@type":"ScholarlyArticle","name":"The persistence of COVID-19 vaccine artifacts in bodily fluids and tissues: a systematic review","author":"Various (systematic review)","isPartOf":{"@type":"Periodical","name":"BMC Infectious Diseases"},"datePublished":"2026","sameAs":"https://doi.org/10.1186/s43094-026-00939-2","url":"https://link.springer.com/article/10.1186/s43094-026-00939-2"},{"@type":"ScholarlyArticle","name":"The dose makes the poison: Translating in vivo and in vitro spike protein concentrations to clinical effects","author":"Halma MTJ, et al.","isPartOf":{"@type":"Periodical","name":"Manuscript / review (in preparation)"},"datePublished":"2026","url":"https://onlinelibrary.wiley.com/doi/full/10.1155/av/7990876"},{"@type":"ScholarlyArticle","name":"Vaccine-derived spike protein and mRNA persist for up to 6 months in blood and tissues of patients with post-acute sequelae following COVID-19 vaccination","author":"Fehrer C, et al.","isPartOf":{"@type":"Periodical","name":"medRxiv (preprint)"},"datePublished":"2024","sameAs":"https://doi.org/10.1101/2024.11.11.24317084","url":"https://www.medrxiv.org/content/10.1101/2024.11.11.24317084v1"},{"@type":"ScholarlyArticle","name":"Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination","author":"Röltgen K, et al.","isPartOf":{"@type":"Periodical","name":"Cell"},"datePublished":"2022","sameAs":"https://doi.org/10.1016/j.cell.2022.01.018","url":"https://www.cell.com/cell/fulltext/S0092-8674(22)00076-9"},{"@type":"ScholarlyArticle","name":"Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2","author":"Tanikawa T, et al.","isPartOf":{"@type":"Periodical","name":"Molecules"},"datePublished":"2022","sameAs":"https://doi.org/10.3390/molecules27238405","url":"https://www.mdpi.com/1420-3049/27/23/8405"},{"@type":"ScholarlyArticle","name":"SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis","author":"Grobbelaar LM, Venter C, Pretorius E","isPartOf":{"@type":"Periodical","name":"Bioscience Reports"},"datePublished":"2021","sameAs":"https://doi.org/10.1042/BSR20210611","url":"https://pubmed.ncbi.nlm.nih.gov/34089662/"},{"@type":"ScholarlyArticle","name":"The SARS-CoV-2 spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling","author":"Avolio E, et al.","isPartOf":{"@type":"Periodical","name":"Clinical Science"},"datePublished":"2021","sameAs":"https://doi.org/10.1042/CS20210735","url":"https://pubmed.ncbi.nlm.nih.gov/34314118/"},{"@type":"ScholarlyArticle","name":"In vitro exposure to the SARS-CoV-2 Spike protein subunit S1 leads to changes in several functional characteristics of human trophoblast cells","author":"Various","isPartOf":{"@type":"Periodical","name":"Placenta"},"datePublished":"2026","sameAs":"https://doi.org/10.1016/j.placenta.2026.01.015","url":"https://doi.org/10.1016/j.placenta.2026.01.015"},{"@type":"ScholarlyArticle","name":"The recombinant spike S1 protein induces injury and inflammation in co-cultures of human alveolar epithelial cells and macrophages","author":"Various","isPartOf":{"@type":"Periodical","name":"PLoS ONE"},"datePublished":"2025","sameAs":"https://doi.org/10.1371/journal.pone.0318881","url":"https://doi.org/10.1371/journal.pone.0318881"},{"@type":"ScholarlyArticle","name":"The spike protein of SARS-CoV-2 induces inflammation and EMT of lung epithelial cells and fibroblasts through the upregulation of GADD45A","author":"Various","isPartOf":{"@type":"Periodical","name":"Open Medicine (Warsaw)"},"datePublished":"2023","sameAs":"https://doi.org/10.1515/med-2023-0779","url":"https://doi.org/10.1515/med-2023-0779"},{"@type":"ScholarlyArticle","name":"Effects of Recombinant SARS-CoV-2 Spike Protein Variants on Platelet Morphology and Activation","author":"Various","isPartOf":{"@type":"Periodical","name":"Seminars in Thrombosis and Hemostasis"},"datePublished":"2024","sameAs":"https://doi.org/10.1055/s-0043-1769939","url":"https://doi.org/10.1055/s-0043-1769939"},{"@type":"ScholarlyArticle","name":"Variant-derived SARS-CoV-2 spike protein does not directly cause platelet activation or hypercoagulability","author":"Various","isPartOf":{"@type":"Periodical","name":"Clinical and Experimental Medicine"},"datePublished":"2023","sameAs":"https://doi.org/10.1007/s10238-023-01091-4","url":"https://doi.org/10.1007/s10238-023-01091-4"},{"@type":"ScholarlyArticle","name":"Inhibition of SARS-CoV-2-Induced NLRP3 Inflammasome-Mediated Lung Cell Inflammation by Triphala-Loaded Nanoparticle Targeting Spike Glycoprotein S1","author":"Various","isPartOf":{"@type":"Periodical","name":"Pharmaceutics"},"datePublished":"2024","sameAs":"https://doi.org/10.3390/pharmaceutics16060751","url":"https://doi.org/10.3390/pharmaceutics16060751"},{"@type":"ScholarlyArticle","name":"Distinct Effects of Respiratory Viral Infection Models on miR-149-5p, IL-6 and p63 Expression in BEAS-2B and A549 Epithelial Cells","author":"Various","isPartOf":{"@type":"Periodical","name":"Cells"},"datePublished":"2024","sameAs":"https://doi.org/10.3390/cells13110919","url":"https://doi.org/10.3390/cells13110919"},{"@type":"ScholarlyArticle","name":"Alveolar epithelial type 2 cell specific loss of IGFBP2 activates inflammation in COVID-19","author":"Various","isPartOf":{"@type":"Periodical","name":"Respiratory Research"},"datePublished":"2025","sameAs":"https://doi.org/10.1186/s12931-025-03187-9","url":"https://doi.org/10.1186/s12931-025-03187-9"},{"@type":"ScholarlyArticle","name":"Luteolin-Rich Extract from Harrisonia perforata (Blanco) Merr. Root Alleviates SARS-CoV-2 Spike Protein-Stimulated Lung Inflammation via Inhibition of MAPK/NLRP3 Inflammasome Signaling Pathways","author":"Various","isPartOf":{"@type":"Periodical","name":"Life (Basel)"},"datePublished":"2025","sameAs":"https://doi.org/10.3390/life15071077","url":"https://doi.org/10.3390/life15071077"},{"@type":"ScholarlyArticle","name":"Luteolin-rich fraction from Perilla frutescens seed meal inhibits spike glycoprotein S1 of SARS-CoV-2-induced NLRP3 inflammasome lung cell inflammation via regulation of JAK1/STAT3 pathway","author":"Various","isPartOf":{"@type":"Periodical","name":"Frontiers in Medicine"},"datePublished":"2022","sameAs":"https://doi.org/10.3389/fmed.2022.1072056","url":"https://doi.org/10.3389/fmed.2022.1072056"},{"@type":"ScholarlyArticle","name":"Hesperetin from Root Extract of Clerodendrum petasites S. Moore Inhibits SARS-CoV-2 Spike Protein S1 Subunit-Induced NLRP3 Inflammasome in A549 Lung Cells via Modulation of the Akt/MAPK/AP-1 Pathway","author":"Various","isPartOf":{"@type":"Periodical","name":"International Journal of Molecular Sciences"},"datePublished":"2022","sameAs":"https://doi.org/10.3390/ijms231810346","url":"https://doi.org/10.3390/ijms231810346"},{"@type":"ScholarlyArticle","name":"The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline","author":"Various","isPartOf":{"@type":"Periodical","name":"International Journal of Molecular Sciences"},"datePublished":"2023","sameAs":"https://doi.org/10.3390/ijms24065597","url":"https://doi.org/10.3390/ijms24065597"}]}0:{"rsc":["$","$1","c",{"children":[["$","div",null,{"children":[["$","script",null,{"type":"application/ld+json","dangerouslySetInnerHTML":{"__html":"$2"}}],"$L3","$L4","$L5","$L6","$L7","$L8"]}],["$L9","$La"],"$Lb"]}],"isPartial":false,"staleTime":300,"varyParams":null,"buildId":"ouB_kPb3CWuV1XWSdyqtI"}
3:["$","header",null,{"className":"mb-8","children":[["$","h1",null,{"className":"text-3xl font-bold tracking-tight text-foreground","children":"Measured Levels & Durations"}],["$","p",null,{"className":"mt-3 max-w-3xl text-lg leading-relaxed text-muted-foreground","children":"Human circulating concentrations (pg/mL), tissue persistence durations, and experimental in vitro/in vivo concentrations — with dose-relevance assessment from the Spike Protein Dose scoping review."}]]}]
4:["$","aside",null,{"role":"note","aria-label":"Medical disclaimer","className":"rounded-lg border border-amber-300/60 bg-amber-50 px-4 py-3 text-sm text-amber-950 dark:border-amber-700/50 dark:bg-amber-950/40 dark:text-amber-100","children":["$","div",null,{"className":"flex gap-3","children":[["$","$Lc",null,{"iconNode":[["path",{"d":"m21.73 18-8-14a2 2 0 0 0-3.48 0l-8 14A2 2 0 0 0 4 21h16a2 2 0 0 0 1.73-3","key":"wmoenq"}],["path",{"d":"M12 9v4","key":"juzpu7"}],["path",{"d":"M12 17h.01","key":"p32p05"}]],"className":"lucide-triangle-alert mt-0.5 h-4 w-4 shrink-0 text-amber-600 dark:text-amber-400","aria-hidden":"true"}],["$","p",null,{"children":[["$","strong",null,{"children":"Disclaimer:"}]," This is not medical advice. Consult a healthcare professional. Data is evolving and subject to scientific revision."]}]]}]}]
5:["$","section",null,{"className":"mt-8","children":[["$","h2",null,{"className":"mb-4 text-xl font-semibold text-foreground","children":"Concentration database"}],["$","p",null,{"className":"mb-4 text-sm text-muted-foreground","children":["Compiled from"," ",["$","a",null,{"href":"https://onlinelibrary.wiley.com/doi/full/10.1155/av/7990876","target":"_blank","rel":"noopener noreferrer","className":"inline-flex items-center gap-1 text-sm text-[#e64a19] underline decoration-[#ff9800]/40 underline-offset-2 hover:text-[#ff9800]","title":"Halma MTJ, et al. (2026). The dose makes the poison: Translating in vivo and in vitro spike protein concentrations to clinical effects","children":["Halma MTJ, et al."," (",2026,")",["$","$Lc",null,{"iconNode":[["path",{"d":"M15 3h6v6","key":"1q9fwt"}],["path",{"d":"M10 14 21 3","key":"gplh6r"}],["path",{"d":"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6","key":"a6xqqp"}]],"className":"lucide-external-link h-3 w-3","aria-hidden":"true"}],["$","span",null,{"className":"sr-only","children":"Opens in new tab"}]]}],","," ",["$","a",null,{"href":"https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.061730","target":"_blank","rel":"noopener noreferrer","className":"inline-flex items-center gap-1 text-sm text-[#e64a19] underline decoration-[#ff9800]/40 underline-offset-2 hover:text-[#ff9800]","title":"Yonker LM, et al. (2023). Circulating spike protein detected in post–COVID-19 mRNA vaccine myocarditis","children":["Yonker LM, et al."," (",2023,")",["$","$Lc",null,{"iconNode":"$5:props:children:1:props:children:2:props:children:4:props:iconNode","className":"lucide-external-link h-3 w-3","aria-hidden":"true"}],["$","span",null,{"className":"sr-only","children":"Opens in new tab"}]]}],","," ",["$","a",null,{"href":"https://link.springer.com/article/10.1186/s43094-026-00939-2","target":"_blank","rel":"noopener noreferrer","className":"inline-flex items-center gap-1 text-sm text-[#e64a19] underline decoration-[#ff9800]/40 underline-offset-2 hover:text-[#ff9800]","title":"Various (systematic review) (2026). The persistence of COVID-19 vaccine artifacts in bodily fluids and tissues: a systematic review","children":["Various (systematic review)"," (",2026,")",["$","$Lc",null,{"iconNode":"$5:props:children:1:props:children:2:props:children:4:props:iconNode","className":"lucide-external-link h-3 w-3","aria-hidden":"true"}],["$","span",null,{"className":"sr-only","children":"Opens in new tab"}]]}],", and experimental studies. Full Spike Protein Dose project CSV import pending OneDrive sync."]}],["$","$Ld",null,{}]]}]
6:["$","section",null,{"className":"mt-10","children":[["$","h2",null,{"className":"mb-4 text-xl font-semibold text-foreground","children":"Charts — human circulating subset"}],["$","div",null,{"className":"grid gap-6 lg:grid-cols-2","children":[["$","$Le",null,{}],["$","$Lf",null,{}]]}]]}]
7:["$","section",null,{"className":"mt-10","children":[["$","h2",null,{"className":"mb-2 text-xl font-semibold text-foreground","children":"Table 2 — Bodily fluids"}],["$","p",null,{"className":"mb-4 text-sm text-muted-foreground","children":["From ",["$","a",null,{"href":"https://link.springer.com/article/10.1186/s43094-026-00939-2","target":"_blank","rel":"noopener noreferrer","className":"inline-flex items-center gap-1 text-sm text-[#e64a19] underline decoration-[#ff9800]/40 underline-offset-2 hover:text-[#ff9800]","title":"Various (systematic review) (2026). The persistence of COVID-19 vaccine artifacts in bodily fluids and tissues: a systematic review","children":["Various (systematic review)"," (",2026,")",["$","$Lc",null,{"iconNode":"$5:props:children:1:props:children:2:props:children:4:props:iconNode","className":"lucide-external-link h-3 w-3","aria-hidden":"true"}],["$","span",null,{"className":"sr-only","children":"Opens in new tab"}]]}]," — blood persistence up to ~709 days in outlier cohorts."]}],["$","$L10",null,{}]]}]
8:["$","section",null,{"className":"mt-10","children":[["$","h2",null,{"className":"mb-2 text-xl font-semibold text-foreground","children":"Table 3 — Tissues (autopsy / biopsy)"}],["$","$L11",null,{}]]}]
9:["$","script","script-0",{"src":"/_next/static/chunks/3fd54t--kwrrb.js","async":true}]
a:["$","script","script-1",{"src":"/_next/static/chunks/2-pirf99i-4ly.js","async":true}]
b:["$","$L12",null,{"children":["$","$13",null,{"name":"Next.MetadataOutlet","children":"$@14"}]}]
14:null